Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-10 1:49 pm Purchase |
2024-08-31 | 13G | Acelyrin, Inc. SLRN |
T. Rowe Price Investment Management, Inc. | 10,498,900 10.500% |
10,498,900 (New Position) |
Filing History |
| 2024-08-12 09:40 am Sale |
2024-08-09 | 13G | Acelyrin, Inc. SLRN |
FMR LLC | 3,884,690 3.922% |
-4,937,581 (-55.97%) |
Filing History |
| 2024-05-20 4:14 pm Purchase |
2024-05-08 | 13G | Acelyrin, Inc. SLRN |
Integrated Core Strategies (US) LLC | 5,145,429 5.200% |
233,184 (+4.75%) |
Filing History |
| 2024-04-19 4:12 pm Purchase |
2024-04-09 | 13G | Acelyrin, Inc. SLRN |
Integrated Core Strategies (US) LLC | 4,912,245 4.990% |
4,912,245 (New Position) |
Filing History |
| 2024-03-28 4:55 pm Purchase |
2023-12-31 | 13G | Acelyrin, Inc. SLRN |
AyurMaya Capital Management Company, LP | 9,334,735 9.600% |
9,334,735 (New Position) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 6,649,442 6.800% |
685,642 (+11.50%) |
Filing History |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | Acelyrin, Inc. SLRN |
The Vanguard Group | 6,155,910 6.320% |
6,155,910 (New Position) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Acelyrin, Inc. SLRN |
FMR LLC | 8,822,271 9.063% |
-432,601 (-4.67%) |
Filing History |
| 2023-10-13 3:59 pm Purchase |
2023-10-09 | 13G | Acelyrin, Inc. SLRN |
FMR LLC | 9,254,872 11.108% |
9,254,872 (New Position) |
Filing History |
| 2023-10-10 09:09 am Purchase |
2023-10-09 | 13G | Acelyrin, Inc. SLRN |
FIL Limited | 9,254,872 11.108% |
9,254,872 (New Position) |
Filing History |
| 2023-05-19 4:06 pm Purchase |
2023-05-09 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 5,963,800 6.100% |
5,963,800 (New Position) |
Filing History |
| 2023-05-19 4:00 pm Purchase |
2023-05-09 | 13D | Acelyrin, Inc. SLRN |
AI ACEL LLC | 5,095,777 5.240% |
5,095,777 (New Position) |
Filing History |
| 2023-05-19 2:54 pm Purchase |
2023-05-09 | 13D | Acelyrin, Inc. SLRN |
Westlake BioPartners Fund II L.P. | 9,852,020 10.100% |
9,852,020 (New Position) |
Filing History |